Samuel A. Funt, MD
Medical Oncologist
Titles
Assistant Attending Physician
Clinical Expertise
Genitourinary Malignancies; Bladder Cancer: Testicular Cancer (Germ Cell Tumors)
We post reviews for MSK healthcare providers who have at least 30 patient experience surveys completed. If you do not see reviews for a provider, it may be because they do not yet have enough survey responses, or the provider may not be part of the group of healthcare providers included in the survey.
Only outpatient providers are included in the survey. Healthcare providers who only work in the hospital or in urgent care are not included in the survey. Pathologists or researchers who do not provide direct care to patients do not have reviews.
New Patient Appointments
Scheduling a visit is easy. Click below or call us to get started.
Dr. Funt accepts the following list of insurance providers. Select your insurance provider to see more details.
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS, Transplant
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): POS, EPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO, DSN
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): HMO, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO, HMO, PPO, POS
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): HMO, PPO
Payor Type: Commercial
In Network Coverage Type(s): PPO EPO
Payor Type: Commercial
In Network Coverage Type(s): HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Commercial
In Network Coverage Type(s): EPO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): PPO, HMO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, EPO
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicaid/Managed Medicaid
In Network Coverage Type(s): State Government
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): Federal Government
Payor Type: Commercial
In Network Coverage Type(s): Supplemental
Payor Type: Commercial
In Network Coverage Type(s): PPO/OAP
Payor Type: Other
In Network Coverage Type(s): PPO, POS, EPO, HMO
Payor Type: Medicare/Medicare Advantage
In Network Coverage Type(s): TBD
Payor Type: Commercial
In Network Coverage Type(s): HMO/EPO
Payor Type: Commercial
In Network Coverage Type(s): PPO, EPO
Payor Type: Commercial
In Network Coverage Type(s): State Government
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, HMO
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS
Payor Type: Commercial
In Network Coverage Type(s): PPO, POS, HMO
Contact and Location
- 646-888-4770 Office Phone
- Speaks English and Spanish
Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
See all locationsAbout Me
Education
MD, Emory University
Residencies
Internal Medicine - New York Presbyterian/Columbia University Medical Center
Fellowships
Medical Oncology - Memorial Sloan Kettering Cancer Center
Board Certifications
Internal Medicine; Medical Oncology
I am a medical oncologist who cares for people with genitourinary cancer. I specialize in treating bladder cancer (urothelial carcinoma) and testicular cancer (germ cell tumors).
I care for hundreds of people with genitourinary cancer each year. Early on in my training, I understood how meaningful and rewarding it is to have trusting relationships with the people in my care. I learned that every patient has a unique medical and social history and each cancer has a particular genetic profile that allows for an increasingly personalized approach to care. At that point, I knew that a career in cancer care would allow me to practice both the art and science of medicine at the highest level.
Read more
Immunotherapy has revolutionized how we care for people with bladder cancer. Most people don’t respond to immunotherapy, however, and we can’t tell ahead of time who will. My research focuses on improving outcomes for people with bladder cancer by leading clinical trials testing immunotherapies. I am also working to develop immune-related biomarkers that can predict who will benefit.
Unfortunately, some men with advanced testicular cancer do not respond to chemotherapy and their disease progresses. These are often young adults in the prime of their lives. To help this group, I am investigating ways to help predict resistance or sensitivity to chemotherapy before treatment begins. I am also studying the effectiveness of immunotherapy in people with relapsed and refractory testicular cancer.
Patients and their caregivers have a universal desire for specialists who listen and respond to their specific concerns about how their diagnosis will affect their everyday life. These can range from managing pain to being well enough to enjoy special events, like a loved one’s wedding or the birth of a grandchild. My goal is to help patients feel confident that my team and I have their best interests in mind and truly care about all aspects of their well-being.
Outside of work, I love spending time with my wife and two young children.
My goal is to help patients feel confident that my team and I have their best interests in mind and truly care about all aspects of their well-being.
-Dr. Funt
Awards and Honors
- Alpha Omega Alpha
- Columbia Univeristy Medical Center John N. Loeb Intern Award
- selected by ASCO/AACR to attend its Methods in Clinical Cancer Research workshop
- Conquer Cancer Foundation’s Young Investigator Award
- Bladder Cancer Advocacy Network’s John Quale Travel Fellowship
- Bochner-Fleisher Research Scholar in Urologic Oncology at Memorial Sloan Kettering Cancer Center
- National Cancer Institute’s K12 Paul Calabresi Career Development Award for Clinical Oncology
Colleagues
Doctors at Memorial Sloan Kettering work as teams, with specialists from all different areas. This allows us to consider all your needs together, and to give you the best possible care.
Clinical Trials
- Clinical Trials Investigated by Dr. Funt
- A Phase I Study of ALX148 Immunotherapy plus Enfortumab Vedotin and/or Other Anticancer Therapies in People with Advanced Urothelial Cancer
- A Phase II Study of Ipilimumab and Nivolumab Immunotherapy plus Cabozantinib to Treat Rare Advanced Genitourinary Cancers
- Clinical Trials Co-Investigated by Dr. Funt
- A Phase IB/II Study of Etigilimab with Nivolumab Immunotherapy in People with Solid Tumors
- A Phase II Study of Rituximab or Tocilizumab to Treat Side Effects After Cancer Immunotherapy that Require Prolonged Steroid Treatment
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Search clinical trialsResearch and Publications
Visit PubMed for a full listing of Dr. Funt’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
See all on PubMedPatient Reviews
At MSK, we’re committed to delivering the best care to every patient. We use feedback from our patients to continue to improve our care. We also post patient reviews online to help you make healthcare choices. Learn more about our patient experience reviews.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Samuel A. Funt discloses the following relationships and financial interests:
-
76Bio, Inc.
Ownership / Equity Interests -
Allogene Therapeutics
Ownership / Equity Interests -
ByHeart, Inc.
Ownership / Equity Interests -
Doximity, Inc.
Ownership / Equity Interests -
IconOVir Bio, Inc.
Ownership / Equity Interests -
Immunai Inc.
Provision of Services (uncompensated)
-
Kronos Bio, Inc
Ownership / Equity Interests -
Merck Sharp & Dohme
Provision of Services -
Neogene Therapeutics Inc
Ownership / Equity Interests -
UroGen Pharma, Inc.
Ownership / Equity Interests -
Vida Ventures, LLC
Ownership / Equity Interests
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2021 through disclosure submission in spring 2022). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
